Coronavirus Puts The Brakes On Mylan-Upjohn Merger
Shareholders Meeting In The Netherlands Also Pushed Back
Mylan and Pfizer’s Upjohn were all set to merge into Viatris by midway through this year, subject to certain approvals, but that will now not happen in that timeframe as the global coronavirus pandemic proves an insurmountable barrier to getting the deal over the line.
